FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutics, namely to a pharmaceutical composition for treating and/or preventing a malignant tumour. Composition contains as an active ingredient an antibody or its fragment with immunological reactivity with respect to protein CSPG5 or its fragment, consisting of at least 7 or more consecutive amino acid residues, where the CSPG5 protein consists of any of the amino acid sequences presented by SEQ ID NO: 8, 4, 6, 10 and 12, or amino acid sequence with amino acid identity with these amino acid sequences 80 % or more.
EFFECT: invention provides the possibility of creating a composition effective for treating and/or preventing a malignant tumour.
4 cl, 5 dwg, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNO-INDUCING AGENT | 2016 |
|
RU2744843C2 |
| HERPES VACCINE | 2019 |
|
RU2731073C1 |
| METHOD FOR PRODUCING L-AMINO ACIDS USING CORYNEBACTERIA USING GLYCINE CLEAVAGE SYSTEM | 2015 |
|
RU2713298C2 |
| BIOSENSOR SYSTEM FOR FAST DETECTION OF DETERMINED COMPONENTS | 2016 |
|
RU2717658C2 |
| METHOD OF PRODUCING PRECURSOR RENAL CELLS | 2016 |
|
RU2730861C2 |
| CHIMERIC PROTEINS BASED ON HUMAN UTROPHIN AND DYSTROPHIN AND USE THEREOF FOR TREATING DUCHENNE MUSCULAR DYSTROPHY | 2021 |
|
RU2767335C1 |
| HIV-1 SUBTYPE A P17 PROTEIN ANTIBODIES | 2019 |
|
RU2727673C1 |
| ANTIBODY TO HUMAN CD73 | 2017 |
|
RU2754058C2 |
| NUCLEIC ACID CONSTRUCTIONS AND VECTORS FOR GENOTHERAPY FOR TREATING WILSON'S DISEASE AND OTHER CONDITIONS | 2015 |
|
RU2745567C2 |
| UNIVERSAL ANTIBODY-MEDIATED BIOSENSOR | 2016 |
|
RU2746486C2 |
